Latest total current liabilities for 688068.SS: $170M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Beijing Hotgen Biotech , Ltd. (688068.SS) currently reports a total current liabilities of $170M as of September 2026. That compares with $260M in the prior-year period — down 37.2% year over year. Use the charts on this page to explore Beijing Hotgen Biotech , Ltd.'s total current liabilities history and peer comparisons.
Beijing Hotgen Biotech , Ltd.'s total current liabilities decreased from $260M to $170M — a 37.2% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Beijing Hotgen Biotech , Ltd. reported $170M in total current liabilities as of September 2026. That compares with $260M in the prior-year period — down 37.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Beijing Hotgen Biotech , Ltd., and consider following 688068.SS for alerts when major investors trade the stock.
Beijing Hotgen Biotech , Ltd. is classified in the Healthcare sector. On total current liabilities, it currently shows $170M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 688068.SS with unrelated industries.